MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 167 filers reported holding MERIDIAN BIOSCIENCE INC in Q1 2014. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $5,710,000 | +25.5% | 413,745 | +60.9% | 0.95% | +22.3% |
| Q4 2016 | $4,551,000 | +362.0% | 257,120 | +438.2% | 0.78% | +288.1% |
| Q1 2016 | $985,000 | +4.6% | 47,775 | +4.0% | 0.20% | -3.4% |
| Q4 2015 | $942,000 | +20.3% | 45,927 | +0.3% | 0.21% | +18.2% |
| Q3 2015 | $783,000 | -2.5% | 45,805 | +6.3% | 0.18% | -3.3% |
| Q2 2015 | $803,000 | +1.3% | 43,087 | +3.6% | 0.18% | -1.1% |
| Q1 2015 | $793,000 | +86.2% | 41,577 | +60.6% | 0.18% | +85.9% |
| Q4 2014 | $426,000 | -2.1% | 25,883 | +5.3% | 0.10% | -6.6% |
| Q3 2014 | $435,000 | -10.7% | 24,575 | +4.1% | 0.11% | -5.4% |
| Q2 2014 | $487,000 | -2.4% | 23,605 | +3.0% | 0.11% | -6.7% |
| Q1 2014 | $499,000 | +26.0% | 22,909 | +53.4% | 0.12% | +26.3% |
| Q4 2013 | $396,000 | +20.4% | 14,933 | +7.3% | 0.10% | +10.5% |
| Q3 2013 | $329,000 | +23.7% | 13,912 | +12.6% | 0.09% | +13.2% |
| Q2 2013 | $266,000 | – | 12,359 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Technologies Management, LLC | 115,571 | $3,034,000 | 2.64% |
| Acuitas Investments, LLC | 160,046 | $4,201,000 | 2.41% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 144,000 | $3,780,000 | 0.78% |
| GLOBEFLEX CAPITAL L P | 158,664 | $4,165,000 | 0.76% |
| CLARK ESTATES INC/NY | 220,000 | $5,775,000 | 0.74% |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 721,176 | $18,931,000 | 0.69% |
| EARNEST PARTNERS LLC | 4,341,834 | $113,973,000 | 0.68% |
| MOODY ALDRICH PARTNERS LLC | 138,844 | $3,645,000 | 0.53% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 889,269 | $23,343,000 | 0.49% |
| Phocas Financial Corp. | 134,740 | $3,537,000 | 0.47% |